Observations on the Nature, Biosynthesis, Secretion and Significance of Endogenous Ouabain

References

• Ringer S. Regarding the influence of the organic constituents of the blood on the contractility of the ventricle. J. Physiology 1885; 6: 361–381
   PubMedGoogle Scholar
• Schatzmann H J. Herzglycoside als hemmstoffe fur den aktiven kalium und natrium transport durch die erythrocyten-membran. Helv. Physiol. Pharmacol. Acta 1953; 11: 346–354
   PubMedGoogle Scholar
• Szent-Gyorgyi A. Chemical Physiology of Contraction in Body and Heart Muscle. Academic Press, New York 1953; 86–91
   Google Scholar
• Skou J C. The influence of some cations on an adenosine triphosphatase from peripheral nerves. Biochim. Biophys. Acta 1957; 23: 394–401
   PubMed Web of Science ®Google Scholar
• Akera T, Larsen F S, Brody T M. Correlation of sodium- and potassium-activated adenosine triphosphatase activity with ouabain-induced inotropic stimulation. J. Pharmacol. Exp. Ther. 1970; 173: 145–151
   PubMed Web of Science ®Google Scholar
• Sweadner K J. Isozymes of the Na/K-ATPase. Biochim. Biophys. Acta 1989; 988: 185–220
   PubMed Web of Science ®Google Scholar
• Juhaszova M, Blaustein M P. Na+pump low and high ouabain affinity α subunit isoforms are differently distributed in cells. Proc. Natl. Acad. Sci. USA 1997; 94: 1800–1805
   PubMed Web of Science ®Google Scholar
• Price E M, Lingrel J B. Structure-function relationships in the Na,K-ATPase alpha subunit: site-directed mutagenesis of glutamine-111 to arginine and asparagine-122 to aspartic acid generates a ouabain-resistant enzyme. Biochemistry 1988; 27: 8400–8408
   PubMed Web of Science ®Google Scholar
• Schonfeld W, Weiland J, Linding C, Masnyk M, Kabat M M, Kurek A, Wicha J, Repke K R. The lead structure in cardiac glycosides is 5β 14β-androstane-3β, 14 diol. Nauyn-Schmeidebergs Arch. Pharmacol. 1985; 329: 414–426
   Google Scholar
• LaBella F S, Bihler I, Templeton J, Lim R-S, Hnatowich M, Rohrer D. Progesterone derivative that bind to the digitalis receptor: effects on Na,K-ATPase and isolated tissues. Fed. Proc. 1985; 44: 2806–2811
   PubMedGoogle Scholar
• Schoner W. Endogenous Digitalis-like factors. Clin. Exp. Hypertens. 1992; A14: 767–814
   Google Scholar
• Goto A, Yamada K, Yagi N, Yoshika M, Sugimoto T. Physiology and pharmacology of endogenous digitalis-like factors. Pharmacol. Rev. 1992; 44: 377–399
   PubMed Web of Science ®Google Scholar
• Ruegg U T. Ouabain-a link in the genesis of high blood pressure?. Experentia 1992; 48: 1102–1106
   PubMedGoogle Scholar
• Harris D W, Clark M A, Fisher J F, Hamlyn J M, Kolbasa K P, Ludens J H, DuCharme D W. Development of an immunoassay for endogenous digitalis-like factor. Hypertension 1991; 17: 936–943
   PubMed Web of Science ®Google Scholar
• Hamlyn J M, Manunta P. Ouabain, Digitalis-like factors and hypertension. J. Hypertension 1992; 10(suppl 7)S99–S111
   Google Scholar
• Hamlyn J M, Blaustein M P, Bova S, DuCharme D W, Harris D W, Mandel F, Mathews W R, Ludens J H. Identification and characterization of a ouabain-like compound from human plasma. Proc. Natl. Acad. Sci. (USA) 1991; 88: 6259–6263
   PubMed Web of Science ®Google Scholar
• Mathews W R, DuCharme D W, Hamlyn J M, Harris D W, Mandel F, Clark M A, Ludens J H. Mass spectral characterization of an endogenous digitalislike factor from human plasma. Hypertension 1991; 17: 930–935
   PubMed Web of Science ®Google Scholar
• Ludens J H, Clark M A, DuCharme D W, Harris D W, Lutzke B S, Mandel F, Mathews W R, Sutter D M, Hamlyn J M. Purification of an endogenous digitalislike factor for structural analysis. Hypertension 1991; 17: 923–929
   PubMed Web of Science ®Google Scholar
• Zhao N, Lo L-C, Berova N, Nakanishi K, Tymiak A A, Ludens J H, Haupert G T. Na,K-ATPase inhibitors from bovine hypothalamus and human plasma are different from ouabain: nanogram scale CD structural analysis. Biochemistry 1995; 34: 9893–9896
   PubMed Web of Science ®Google Scholar
• Ludens J H, Clark M A, Robinson F G, DuCharme D W. Rat adrenal cortex is a source of circulating ouabainlike compound. Hypertension 1992; 19: 721–724
   PubMed Web of Science ®Google Scholar
• Manunta P, Rogowski A C, Hamilton B P, Hamlyn J M. Ouabain-induced hypertension in the rat: relationships among circulating and tissue ouabain and blood pressure. J. Hypertension 1994; 12: 549–560
   PubMed Web of Science ®Google Scholar
• Hamlyn J M, Hamilton B P, Manunta P. Endogenous ouabain, sodium balance and blood pressure: a review and a hypothesis. J. Hypertension 1996; 14: 151–167
   PubMed Web of Science ®Google Scholar
• Laredo J, Hamilton B P, Hamlyn J. M. Ouabain is secreted by bovine adrenocortical cells. Endocrinology 1994; 135: 794–797
   PubMed Web of Science ®Google Scholar
• Laredo J, Hamilton B P, Hamlyn J M. Secretion of Endogenous Ouabain from Bovine Adrenocortical Cells: Role of the Zona Glomerulosa and Zona Fasciculata. Biochem. Biophys. Res. Comm. 1995; 212: 487–493
   PubMed Web of Science ®Google Scholar
• Laredo J, Shah J R, Lu Z-R, Hamilton B P, Hamlyn J M. Angiotensin II stimulates secretion of endogenous ouabain from bovine adrenocortical cells via angiotensin type-2 (AT2) receptors. Hypertension 1997; 29(2)401–407
   PubMedGoogle Scholar
• Shah J R, Laredo J, Hamilton B P, Hamlyn J M. Different signaling pathways mediate stimulated secretions of endogenous ouabain and aldosterone from bovine adrenocortical cells. Hypertension 1998; 31, In press
   PubMed Web of Science ®Google Scholar
• DeWardener H E, MacGregor G A. The role of a circulating inhibitor of Na,K-ATPase in essential hypertension. Am. J. Nephrol. 1983; 3: 88–91
   PubMed Web of Science ®Google Scholar
• Haddy F J, Overbeck H. The role of humoral agents in volume expanded hypertension. Life Sci. 1976; 19: 935–948
   PubMed Web of Science ®Google Scholar
• Blaustein M P. Sodium ions calcium ions and blood pressure regulation and hypertension: an hypothesis. Am. J. Physiol. 1977; 232: C165–C173
   PubMed Web of Science ®Google Scholar
• Yuan C, Manunta P, Hamlyn J M, Chen S, Bohen E, Yeun J, Haddy F J, Pamnani M B. Long term ouabain administration produces hypertension in rats. Hypertension 1993; 22: 178–187
   PubMed Web of Science ®Google Scholar
• Huang B S, Huang X, Harmsen E, Leenen F HH. Chronic central versus peripheral ouabain, BP and sympathetic activity in rats. Hypertension 1994; 23(part 2)1087–1090
   PubMedGoogle Scholar
• Aileru A, Hamilton J, Taylor G, Hamlyn J, Weinreich D. Enhanced efficacy of nicotinic synaptic transmission in superior cervical ganglia from inbred hypertensive rats. FASEB J. 1997; 11(3)A633, abstract 3654
   Google Scholar
• Aileru A A, Taylor G, Hamlyn J, Hamilton M, Weinreich D. Nicotinic synaptic transmission in rat superior cervical ganglia is enhanced in ouabain-induced hypertension. Abstracts of the 27th Annual Meeting of the Society for Neuroscience, New Orleans, October, 25–30, 1997; 23, 1180, abstract 469.18
   Google Scholar
• Kimura K., Manunta P., Hamilton B. P., Hamlyn J. M. Augmented contractility of the renal artery in ouabain-induced hypertension. J. Hypertension 1994; 12: S158, abstract 871
   Google Scholar
• Rossi G P, Manunta P, Hamlyn J M, Pavan E, De Toni R, Semplicini A, Pessina A C. Immunoreactive endogenous ouabain in primary aldosteronism and essential hypertension: relationship with plasma renin, aldosterone and blood pressure levels. J. Hypertension 1995; 13: 1181–1191
   PubMed Web of Science ®Google Scholar
• Gottlieb S S, Rogowski A C, Weinberg M, Krichten C M, Hamilton B P, Hamlyn J M. Elevated concentrations of endogenous ouabain in patients with congestive heart failure. Circulation 1992; 86: 420–425
   PubMed Web of Science ®Google Scholar